FEMALE VERSUS MALE BURDEN OF PSORIATIC ARTHRITIS IS HIGHER AND TREATMENT
PERSISTENCE SHORTER AFTER USTEKINUMAB OR TUMOUR NECROSIS FACTOR
INHIBITOR TREATMENT: 1-YEAR DATA FROM THE PSABIO STUDY
FEMALE VERSUS MALE BURDEN OF PSORIATIC ARTHRITIS IS HIGHER AND TREATMENT PERSISTENCE SHORTER AFTER USTEKINUMAB OR TUMOUR NECROSIS FACTOR INHIBITOR TREATMENT: 1-YEAR DATA FROM THE PSABIO STUDY
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Έτος δημοσίευσης:
2021
Συγγραφείς:
van der Horst-Bruinsma, I. Nurmohamed, M. Van Kuijk, A. and Siebert, S. Bergmans, P. De Vlam, K. Gremese, E. and Joven-Ibanez, B. Korotaeva, T. Noel, W. Sfikakis, P. and Theander, E. Smolen, J. S. Gossec, L.
